Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis

SIMPLE SUMMARY: Elderly patients with recurrent or metastatic head and neck squamous cell carcinoma are a unique subset because they are at increased risks of miserable prognosis. Although cisplatin, 5-fluorouracil plus cetuximab (EXTREME) is the most commonly used regimen, chemotherapy de-escalatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng-Che, Wang, Chih-Chun, Yang, Chuan-Chien, Lien, Ching-Feng, Wang, Chien-Chung, Shih, Yu-Chen, Yeh, Shyh-An, Hwang, Tzer-Zen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533478/
https://www.ncbi.nlm.nih.gov/pubmed/34681110
http://dx.doi.org/10.3390/biology10101011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533478/
https://www.ncbi.nlm.nih.gov/pubmed/34681110
http://dx.doi.org/10.3390/biology10101011

Ejemplares similares